Loading company…
Prologue Medicines uses viral proteins and computational methods to identify potential therapies.
Founded in 2021, Prologue Medicines is a biotechnology company based in Massachusetts, US. Its DELVE platform analyzes viral proteins and their relationships with human biology to identify proteins that may affect human physiology and inform therapeutic research. Flagship Pioneering formed the company for USD 50 million in May 2024. The transaction supports development of the DELVE platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in